Plain-English translation of NCT05973786 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether people with bipolar depression who didn't improve on their first medication benefit from switching to a more intensive combination of treatments. You would receive either an intensified regimen—which could include , , , or combined with , , or —or a standard combination of with or . The study lasts six weeks and aims to help doctors figure out the best way to treat bipolar depression when the first try doesn't work.
Bipolar depression is often the most difficult and longest-lasting part of bipolar disorder, and many patients don't respond well to their first medication. There's no clear agreement among doctors about when to add extra medications or what combination works best, so this trial is testing whether a more intensive approach earlier in treatment could help more people feel better.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic multiple times over six weeks for assessments of your mood and how well you're functioning. You would be randomly assigned to either the intensified medication combination or the standard combination, and you would take these new medications as directed. The research team would monitor your symptoms, side effects, and overall progress throughout the study to see which approach works better for people like you.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Austria
Germany